PRN Profound Medical Corp.

6.669USD9.540 CAD · TSX-2.95%Mkt Cap: 244.26M USDP/E: —

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The compa…

Institutional holders20 on file

Key Statistics

Company
Market Cap244.26M USD
Enterprise Value226.10M USD
Revenue (TTM)23.63M USD
Gross Profit11.39M USD
Net Income (TTM)-42.57M USD
Revenue/Share0.68 USD
Last Price6.669 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees162
CountryCA
SectorHealthcare
IndustryMedical Devices
ISINCA74319B5027
Valuation
P/E (Trailing)—
P/E (Forward)-11.06
PEG—
EV/EBITDA-9.57
EV/Revenue9.57
P/S14.79
P/B5.85
EPS (TTM)-1.30 USD
EPS (Forward)-0.86 USD
52W Range
4.55851% of range8.668
52W High8.668 USD
52W Low4.558 USD
Profitability
Gross Margin70.77%
Oper. Margin-145.08%
EBITDA Margin-143.06%
Profit Margin-264.44%
ROE-64.08%
ROA-54.95%
ROIC-361.15%
ROCE-57.78%
Growth
Revenue Growth85.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-38.21M USD
CapEx (TTM)242.00K USD
FCF Margin-85.28%
FCF Yield-8.25%
Net Debt-25.98M USD
Net Debt/EBITDA0.77
Net Debt/FCF—
Balance Sheet
Debt/Equity0.07
Current Ratio4.54
Quick Ratio3.67
Book Value/Sh1.63 USD
Cash/Share0.91 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateOct 16, 2019
Splits
Last Split1:10
Split DateOct 16, 2019
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.36.63M
Float35.60M
Insiders4.12%
Institutions45.08%
Short Interest
Short Ratio21.1d
Short % Float1.02%
Short % Out.0.90%
Shares Short328.75K
Short (prev mo.)338.98K
Technical
SMA 506.228 (+7.1%)
SMA 2006.453 (+3.4%)
Beta0.56
S&P 52W Chg12.00%
Avg Vol (30d)19.56K
Avg Vol (10d)19.61K
Technical Indicators
RSI (14)49.4
MACD0.3704
MACD Signal0.4139
MACD Hist.-0.0435
BB Upper8.174 USD
BB Middle6.683 USD
BB Lower5.192 USD
BB Width44.62%
ATR (14)0.4037 USD
Vol Ratio (20d)0.60x

About Profound Medical (TSE: PRN)

›

Profound Medical (TSE: PRN) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 162 employees.

The shares were at 9.540 CAD on 19 November 2026, up 11.2% over 52 weeks. Its 52-week range is 6.520 CAD to 12.40 CAD: the price is 23.1% below the high and 46.3% above the low.

Its market capitalisation is 349.42M CAD.

Profound Medical reports return on equity of -64.1%, an operating margin of -145.1% and revenue up 85.9% year over year.

It holds more cash than debt, a net cash position of 25.98M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. The next earnings report is expected on 4 March 2027.